References
- Chappell LC, Cluver CA, Kingdom J, Tong S. Pre-eclampsia. Lancet. 2021;398(10297):341–354.
- Brown MA, Magee LA, Kenny LC, Karumanchi SA, McCarthy FP, Saito S, et al. The hypertensive disorders of pregnancy: ISSHP classification, diagnosis and management recommendations for international practice. Pregnancy Hypertens. 2021;27:148–169.
- Dimitriadis E, Rolnik DL, Zhou W, Estrada-Gutierrez G, Koga K, Francisco RPV, et al. Pre-eclampsia. Nat Rev Dis Primers. 2023;9(1):8.
- Staff AC, Benton SJ, von Dadelszen P, Roberts JM, Taylor RN, Powers RW, et al. Redefining preeclampsia using placenta-derived biomarkers. Hypertension. 2022;79(3):562–572.
- Zeisler H, Llurba E, Chantraine F, Vatish M, Staff AC, Sennström M, et al. Predictive value of the sFlt-1/PlGF ratio in women with suspected preeclampsia. Pregnancy Hypertens. 2022;29:15–23.
- Llurba E, Crispi F, Verlohren S. Update on angiogenic biomarkers in the management of preeclampsia and fetal growth restriction. Ultrasound Obstet Gynecol. 2023; 61(1):9–21.
- Stepan H, Hund M, Andraczek T. Combining biomarkers to predict, diagnose and monitor pre-eclampsia: current evidence and future directions. Pregnancy Hypertens. 2022;27:150–158.
- Hauspurg A, Countouris ME, Catov JM, Himes KP. Hypertensive disorders of pregnancy and future maternal health: epidemiology and mechanisms. BMJ. 2023;382:e074363.
- Ghulmiyyah L, Sibai B. Maternal mortality from preeclampsia/eclampsia. Semin Perinatol. 2022;46(5): 151594.
- McCarthy FP, Gill C, Seed PT, Bramham K, Chappell LC. Contemporary concepts in pre-eclampsia: a state-of-the-art review. Nat Rev Nephrol. 2024;20(2):85–104.
- Chiarello DI, Salsoso R, Toledo F, Mate A, Vázquez CM, Sobrevia L. Endothelial dysfunction and immune dysregulation in preeclampsia. Front Physiol. 2022; 13:812549.
- Cindrova-Davies T. Oxidative stress, placental stress and antiangiogenic factors in preeclampsia. Free Radic Biol Med. 2022;188:214–226.
- Than NG, Romero R, Tarca AL, Dragovic R, Xu Y, Dong Z, et al. Integrated placental omics in preeclampsia: emerging molecular pathways. Am J Obstet Gynecol. 2023;229(2):123–139.
- Roberts JM, Hubel CA. The elusive etiology of preeclampsia: what we know in 2024. Hypertension. 2024;81(3):487–498.
- Staff AC. The two-stage placental model of preeclampsia: an update. J Reprod Immunol. 2023;156:103788.
- Poon LC, Shennan A, Hyett JA, Kapur A, Hadar E, Divakar H, et al. FIGO initiative on pre-eclampsia: practical recommendations for first-trimester screening and prevention. Int J Gynaecol Obstet. 2023;160 Suppl 1:3–18.
- National Institute for Health and Care Excellence. Hypertension in pregnancy: diagnosis and management (NG133). London: NICE; 2023.
- American College of Obstetricians and Gynecologists. Gestational hypertension and preeclampsia: clinical practice update. Obstet Gynecol. 2024;143(6):e1–e25.
- World Health Organization. WHO recommendations on antenatal care and prevention of hypertensive disorders in pregnancy. Geneva: WHO; 2023.
- Abalos E, Cuesta C, Grosso AL, Chou D, Say L. Global and regional estimates of preeclampsia and eclampsia: updated burden analysis. Pregnancy Hypertens. 2021;25:122–130.
- Bilano VL, Ota E, Ganchimeg T, Mori R, Souza JP. Risk factors of pre-eclampsia/eclampsia and adverse outcomes in low- and middle-income countries: updated multicountry analysis. BMC Pregnancy Childbirth. 2021;21:449.
- Duhig KE, Myers J, Seed PT, Sparkes J, Lowe J, Shennan AH, et al. Geographic variation in preeclampsia incidence and severity: a multinational cohort analysis. Pregnancy Hypertens. 2023;31:85–93.
- von Dadelszen P, Magee LA, Payne B, Hall DR, Bhutta ZA, et al. Maternal outcomes in hypertensive disorders of pregnancy in low-resource settings: updated evidence. Lancet Glob Health. 2022;10(9):e1295–e1304.
- Magee LA, von Dadelszen P, Stones W, Mathai M. Contemporary clinical framework for hypertensive disorders of pregnancy. Int J Gynaecol Obstet. 2022;158 Suppl 1:1–12.
- Phipps E, Prasanna D, Brima W, Jim B. HELLP syndrome and severe preeclampsia: contemporary diagnosis and management. Clin Obstet Gynecol. 2022;65(1):92–106.
- Vikse BE, Irgens LM, Leivestad T, Skjærven R, Iversen BM. Acute kidney injury and placental complications in preeclampsia: updated cohort evidence. Kidney Int Rep. 2023;8(4):1012–1021.
- Redman CW, Staff AC. Preeclampsia, syncytiotrophoblast stress, biomarkers and systemic disease: a contemporary reappraisal. Placenta. 2021;112:1–7.
- Rana S, Burke SD, Karumanchi SA. Imbalances of angiogenic and antiangiogenic factors in preeclampsia. Annu Rev Med. 2022;73:293–308.
- Kaitu’u-Lino TJ, Hannan NJ, Brownfoot FC, Hastie R, Cannon P, Nguyen TV, et al. Preeclampsia: molecular mechanisms and multifactorial origins. Nat Rev Dis Primers. 2024;10(1):12.
- Say L, Chou D, Gemmill A, Tunçalp Ö, Moller AB, Daniels J, et al. Global causes of maternal death: a WHO systematic analysis. Lancet Glob Health. 2021; 9(7):e951–e962.
- Green BN, Johnson CD, Adams A. Writing narrative reviews in biomedicine: updated practical guidance. J Chiropr Med. 2021;20(4):233–241.
- Murad MH, Asi N, Alsawas M, Alahdab F. New evidence pyramid and review hierarchy in evidence-based medicine. J Clin Epidemiol. 2021;129:105–112.
- Torres-Torres J, Espino-y-Sosa S, Martinez-Portilla R, Borboa-Olivares H, Estrada-Gutierrez G, Acevedo-Gallegos S, et al. A narrative review on the pathophysiology of preeclampsia. Int J Mol Sci. 2024; 25(14):7569. Grimes DA, Schulz KF. Narrative synthesis in clinical reviews: common pitfalls and how to avoid them. Clin Obstet Gynecol. 2022;65(2):233–241.
- Chaiworapongsa T, Romero R, Erez O, Tarca AL, Edlow AG, Hsu CD, et al. Evidence supporting a role for soluble endoglin in the pathogenesis of preeclampsia and its effect on TGF-β signaling and endothelial dysfunction. Front Med (Lausanne). 2023;10:1173030
- Preeclampsia with aspirin in high-risk women: contemporary evidence update. Am J Obstet Gynecol. 2022;226(2S):S1108–S1121.
- Roberge S, Bujold E, Nicolaides KH. Low-dose aspirin for prevention of preeclampsia and fetal growth restriction: updated meta-analysis. Ultrasound Obstet Gynecol. 2023;62(4):456–467.
- Meher S, Duley L, Hunter KE, Askie LM. Antiplatelet therapy before 16 weeks for prevention of preeclampsia: individual participant data meta-analysis update. Lancet. 2022;399(10331):1210–1221.
- Hofmeyr GJ, Betrán AP, Singata-Madliki M, Cormick G, Munjanja SP, Fawcus S, et al. Calcium supplementation during pregnancy for preventing hypertensive disorders and related problems: updated review. Cochrane Database Syst Rev. 2021;10(10):CD001059.
- Cormick G, Ciapponi A, Cafferata ML, Belizán JM. Calcium supplementation for prevention of preeclampsia: an updated systematic review and meta-analysis. Am J Obstet Gynecol. 2021;224(5):505–518.
- Magee LA, Singer J, von Dadelszen P, Rey E, Ross S, Asztalos E, et al. The CHIPS randomized trial follow-up: less-tight versus tight control of hypertension in pregnancy. Pregnancy Hypertens. 2021;24:94–101.
- Webster K, Fishburn S, Maresh M, Findlay SC, Chappell LC. Diagnosis and management of hypertension in pregnancy: summary of updated recommendations. BMJ. 2022;377:e067849.
- Easterling T, Mundle S, Bracken H, Parvekar S, Mool S, Magee LA, et al. Oral antihypertensive regimens for severe hypertension in pregnancy in low-resource settings: updated comparative evidence. Lancet. 2022; 399(10328):1450–1460.
- Magee LA, von Dadelszen P, Rey E, Ross S, Asztalos E, Murphy KE, et al. Severe hypertension in pregnancy: current antihypertensive strategies and outcomes. Obstet Gynecol. 2023;141(4):701–713.
- Duley L, Meher S, Abalos E. Magnesium sulphate for women with pre-eclampsia and eclampsia: current evidence update. Cochrane Database Syst Rev. 2022;3(3):CD000025.
- Koopmans CM, Bijlenga D, Groen H, Vijgen SMC, Aarnoudse JG, Bekedam DJ, et al. Timing of delivery in women with hypertensive disorders of pregnancy: up-dated evidence synthesis. BJOG. 2022;129(8):1265–1276.
- Ganzevoort W, Thornton JG, Marlow N, Thilaganathan B, Chappell LC. Planned early delivery versus expectant management in late preterm preeclampsia: contemporary review. Lancet Child Adolesc Health. 2023; 7(4):261–272.
- Mol BW, Roberts CT, Thangaratinam S, Magee LA, de Groot CJM, Hofmeyr GJ. Pre-eclampsia. Lancet. 2021;387(10022):999–1011.
- Behrens I, Basit S, Melbye M, Lykke JA, Wohlfahrt J, Bundgaard H, et al. Risk of post-pregnancy hypertension and cardiovascular disease after preeclampsia: updated population-based cohort. Hypertension. 2022; 79(7):1578–1588.
- Honigberg MC, Riise HKR, Daltveit DS, Tell GS, Igland J, Iversen AC, et al. Long-term cardiovascular risk after hypertensive disorders of pregnancy: a contemporary cohort study. J Am Coll Cardiol. 2023;81(9):886–898.
- Wu P, Haththotuwa R, Kwok CS, Babu A, Kotronias RA, Rushton C, et al. Preeclampsia and future cardiovascular health: an updated systematic review and meta-analysis. Circulation. 2021;143(10):973–985.
- Bokslag A, van Weissenbruch M, Mol BW, de Groot CJM. Preeclampsia and long-term maternal cardiovascular disease: recent advances. Maturitas. 2022;158:14–21.
- Leon LJ, McCarthy FP, Direk K, Gonzalez-Izquierdo A, Prieto-Merino D, Casas JP, et al. Preeclampsia and cardiovascular disease in offspring: updated epidemiological evidence. Heart. 2022;108(5):372–379.
- Auger N, Fraser WD, Healy-Profitós J, Arbour L. Association between preeclampsia and long-term metabolic outcomes in offspring: a contemporary cohort study. JAMA Netw Open. 2023;6(7):e2321456.
- Wright D, Syngelaki A, Akolekar R, Poon LC, Nicolaides KH. Competing risks model in screening for preeclampsia by maternal factors and biomarkers: contemporary validation. Fetal Diagn Ther. 2021;48(2):81–92.
- Thilaganathan B, Kalafat E. Cardiovascular system in preeclampsia and future disease risk. Ultrasound Obstet Gynecol. 2022;59(5):557–565.
- Kingdom JC, Audette MC, Hobson SR, Windrim RC, Morgen E. A placenta clinic approach to the diagnosis and management of placental dysfunction. Am J Obstet Gynecol. 2022;226(2S):S1035–S1048.
- Staff AC, Georgiou HM, Fell DB, Benton SJ, von Dadelszen P. Biomarker-guided pathways in suspected preeclampsia: clinical implementation review. Pregnancy Hypertens. 2024;35:45–58.
- Verlohren S, Herraiz I, Lapaire O, Schlembach D, Zeisler H, Calda P, et al. The sFlt-1/PlGF ratio in different clinical settings of suspected preeclampsia: updated multicenter evidence. Am J Obstet Gynecol. 2022; 226(3):397.e1–397.e14.
- Vatish M, Crovetto F, Kublickas M, Etchegaray A, Valenzuela FJ, Parra-Cordero M, et al. Angiogenic biomarkers in triage of hypertensive disorders of pregnancy: clinical utility in 2023. Ultrasound Obstet Gynecol. 2023;62(2):155–167.
- Escudero C, Herlitz K, Troncoso F, Acurio J, Aguayo C, Roberts JM, et al. Role of extracellular vesicles and microRNAs on dysfunctional angiogenesis during preeclamptic pregnancies. Front Physiol. 2016;7:98.
- Saito S, Shiozaki A, Nakashima A, Sakai M, Sasaki Y. The role of immune cells and cytokines in preeclampsia. J Reprod Immunol. 2022;150:103468.
- Laresgoiti-Servitje E. A leading role for the immune system in the pathophysiology of preeclampsia. J Leukoc Biol. 2021;109(4):769–781.
- Roberts JM, Escudero C. The placenta in preeclampsia: dysfunctional angiogenesis and systemic endothelial disease. Placenta. 2022;120:12–20.
- Rana S, Lemoine E, Granger JP, Karumanchi SA. Preeclampsia: pathophysiology, challenges, and perspectives. Circ Res. 2022;130(8):1176–1195.
- Thadhani R, Kisner T, Hagmann H, Bossung V, Noack S, Schaarschmidt W, et al. Removal of sFlt-1 in preeclampsia: mechanistic and translational update. Kidney Int. 2021;99(2):289–300.
- Huppertz B. Traditional and new routes of trophoblast invasion and spiral artery remodeling in preeclampsia. Int J Mol Sci. 2022;23(3):1423.
- Burton GJ, Redman CW, Roberts JM, Moffett A. Decidual and placental origins of preeclampsia: contemporary concepts. Placenta. 2021;104:1–7.
- Siegler Y, Melamed N, Barrett J, et al. Preeclampsia in twin pregnancies: time for differential risk assessment and management. Eur J Obstet Gynecol Reprod Biol. 2025;302:120–126.
- Tagami K, Saito M, Kumasawa K, et al. Twin pregnancies and risk of hypertensive disorders of pregnancy: a large prospective cohort study. Hypertens Res. 2025; 48(2):210–218.
- Landau Rabbi M, Sharabi-Nov A, Svirsky R, Yinon Y, Schiff E, Weiner E. The impact of assisted reproductive technology on preeclampsia risk in twin pregnancies: results of the Pre-Twin Screen Study. Ultrasound Obstet Gynecol. 2025;65(3):412–419.
- Deng Q, Li Y, Wang H, Zhang X, Chen J, Liu P, et al. Pregnancy outcomes following assisted reproductive technology in advanced maternal age: a cohort study. Int J Womens Health. 2025;17:45–56.
- AlSubai A, Baqai MH, Agha H, Shankarlal N, Javaid SS, Jesrani EK, et al. Vitamin D and preeclampsia: A systematic review and meta analysis. SAGE Open Med. 2023;11:20503121231212093.
- Fogacci S, Fogacci F, Banach M, Michos ED, Hernandez AV, Lip GYH, et al. Vitamin D supplementation and incident preeclampsia: A systematic review and meta analysis of randomized clinical trials. Clin Nutr. 2020;39(6):1742–1752.
- Moghib K, Ghanm TI, Abunamoos A, Rajabi M, Moawad SM, Mohsen A, et al. Efficacy of vitamin D supplementation on the incidence of preeclampsia: a systematic review and meta analysis. BMC Pregnancy Childbirth. 2024;24: (Article 2024). doi:10.1186/s12884024 07081y.
- Dahma G, Reddy G, Craina M, Dumitru C, Popescu A, Stelea L, et al. The effects of vitamin D supplementation before 20 weeks of gestation on preeclampsia: a systematic review. J Pers Med. 2023;13(6):996.
Language: English
Submitted on: Apr 15, 2026
Accepted on: Jun 9, 2026
Published on: Jul 18, 2026
Published by: University of Kragujevac, Faculty of Medical Sciences
In partnership with: Paradigm Publishing Services
Keywords:
Related subjects:
© 2026 Dragan Lončar, published by University of Kragujevac, Faculty of Medical Sciences
This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 License.